The Academy of Managed Care Pharmacy (AMCP) is pleased provide comments to the Centers for Medicare & Medicaid Services (CMS) in response to the proposed rule “Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency [CMS-4187-P]” published in the Federal Register on October 18, 2018. AMCP appreciates the opportunity to leverage our members’ expertise in offering feedback on this proposed rule and we look forward to continued dialogue with CMS on ways to improve drug price transparency and make medications more affordable for patients.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
